Lv11
16 积分 2024-01-22 加入
A Quantitative Systems Pharmacology Modeling Framework for Evaluation of Cytokine Release Mediated By Intravenous Odronextamab Monotherapy in Patients with B-Cell Non-Hodgkin Lymphoma
1小时前
求助中
Mechanistic Projection of First‐in‐Human Dose for Bispecific Immunomodulatory P‐Cadherin LP‐DART: An Integrated PK/PD Modeling Approach
2小时前
已完结
MODELING DRUG-ORGAN INTERACTIONS AND OPTIMIZING IMMUNOTHERAPY: A QUANTITATIVE SYSTEMS PHARMACOLOGY AND ODRONEXTAMAB DYNAMICS
4小时前
求助中
T cell engagers in autoimmune diseases
6天前
已完结
Errata: Ways to Fit a PK Model with Some Data Below the Quantification Limit, Stuart L. Beal, J. Pharmacokin. Pharmacodyn. 28:481–504 (2001)
21天前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
25天前
已完结
B-cell depletion in autoimmune diseases
27天前
已完结
Pharmacokinetic Variability of Therapeutic Antibodies in Humans: A Comprehensive Review of Population Pharmacokinetic Modeling Publications
2个月前
已完结
Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
3个月前
已完结
Physiologically Based Pharmacokinetic (PBPK) Modeling of Antidepressants: A Scoping Review of Existing Models, Applications, and Software Tools
3个月前
已完结
皖公网安备34019202002308
